166 related articles for article (PubMed ID: 29039348)
1. The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosus.
Klonowska-Szymczyk A; Kulczycka-Siennicka L; Robak T; Smolewski P; Cebula-Obrzut B; Robak E
Postepy Hig Med Dosw (Online); 2017 Oct; 71(0):867-875. PubMed ID: 29039348
[TBL] [Abstract][Full Text] [Related]
2. Correlation between TLR9 Expression and Cytokine Secretion in the Clinical Diagnosis of Systemic Lupus Erythematosus.
Rao H; Zeng Q; Liang Y; Xiao C; Xie S; Xu X
Mediators Inflamm; 2015; 2015():710720. PubMed ID: 26457008
[TBL] [Abstract][Full Text] [Related]
3. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K
Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
Mortezagholi S; Babaloo Z; Rahimzadeh P; Namdari H; Ghaedi M; Gharibdoost F; Mirzaei R; Bidad K; Salehi E
Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 Alters the Expression of Toll-like Receptors in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus.
Yazdanpanah E; Mahmoudi M; Sahebari M; Rezaieyazdi Z; Esmaeili SA; Tabasi N; Jaberi S; Sahebkar A; Rastin M
J Cell Biochem; 2017 Dec; 118(12):4831-4835. PubMed ID: 28544067
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Klonowska-Szymczyk A; Wolska A; Robak T; Cebula-Obrzut B; Smolewski P; Robak E
Mediators Inflamm; 2014; 2014():381418. PubMed ID: 24692849
[TBL] [Abstract][Full Text] [Related]
10. [Expression of interleukin-6 and its receptors in peripheral blood of patients with systemic lupus erythematosus].
Liu X; Lin H; Yuan G; Huang F
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):448-50. PubMed ID: 11798678
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
[TBL] [Abstract][Full Text] [Related]
12. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
13. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
Tsao JT; Hsieh SC; Chiang BL; Yu CL; Lin SC
Clin Exp Med; 2012 Sep; 12(3):153-8. PubMed ID: 22057691
[TBL] [Abstract][Full Text] [Related]
14. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
17. The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.
Zhu YY; Su Y; Li ZG; Zhang Y
PLoS One; 2012; 7(8):e44131. PubMed ID: 22952899
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.
Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM; Hall VC; Fukuda M
Lupus; 1994 Apr; 3(2):97-102. PubMed ID: 7920621
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study.
Chan EY; Lau CS; Zola H
J Clin Pathol; 1996 Aug; 49(8):660-3. PubMed ID: 8881918
[TBL] [Abstract][Full Text] [Related]
20. Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients.
Nasr AS; Fawzy SM; Gheita TA; El-Khateeb E
Z Rheumatol; 2016 Jun; 75(5):502-7. PubMed ID: 26680366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
